Please login to the form below

Not currently logged in
Email:
Password:

Research Partnership promotes Will Tolley

He moves up to associate director of quantitative research

Research Partnership Will TolleyIndependent healthcare market research and consulting agency the Research Partnership has promoted Will Tolley to associate director of quantitative research.

He joined the firm as research manager in March from Millward Brown, where he spent nine years, most recently as insight manager. Prior to that he served at Adelphi for four years as a senior research executive.

The Research Partnership's quantitative director Karen Swords said: “Will's promotion is integral to our objective of continuing to expand our quantitative services, particularly in our key areas of expertise - advanced analytics such as segmentation or demand assessments and brand tracking.

“In the past six months Will has worked on a number of high profile quantitative projects for Research Partnership and received very positive praise from both clients and our internal project teams.”

23rd June 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget....

Infographics